Arcadia Capital Advises InformedDNA on Divestiture of Genetic Testing Utilization Management Business Unit to Zyter

Published on: April 15, 2025

xx

Previous
Previous

Music Royalties & Rights Data Software M&A and Growth Equity Update

Next
Next

Arcadia Capital Expands Tech and Tech Services Coverage with Senior Hire of Jon Wesner